AUDIO SUMMARY

In sheep undergoing general anaesthesia does inclusion of medetomidine result in hypoxaemia?

Rachael Gregson, BVM&S FHEA CertAVP Dip.ECVAA MRCVS1*


1 Large Animal Research and Imaging Facility, The Roslin Institute, The University of Edinburgh, EH25 9RG
* Corresponding author email: rachael.gregson@ed.ac.uk

Published: 13 May 2025

DOI: https://doi.org/10.18849/ve.v10i2.708

In this Audio Summary, Rachael Gregson asks, in healthy adult female non-pregnant sheep undergoing general anaesthesia for research studies, does the inclusion of intravenous medetomidine as part of the anaesthetic protocol cause hypoxaemia? Read the full Knowledge Summary here. 

Audio Summaries are a free resource that enable vets and vet nurses to more quickly and more easily access and digest relevant and up-to-date evidence! A time-saving way to make better and faster evidence-based decisions.

Audio Summary Transcript

My name is Rachael Gregson and I am a veterinary anaesthetist working at the University of Edinburgh. In this Knowledge Summary, I was looking at the evidence regarding the development of hypoxaemia, as indicated by arterial partial pressure of oxygen, in healthy adult female sheep undergoing general anaesthesia for research purposes. I chose this question because although it is recognised that alpha-2 adrenoreceptor drugs such as medetomidine cause hypoxaemia, the incidence and clinical significance of the hypoxaemia caused by medetomidine is often hard to predict.

The literature search yielded four papers. All were experimental studies. Three were crossover experimental studies, one of which was run concurrently with another study looking at nutrition, and the fourth was run in parallel with an orthopaedic research study. None of the studies were specifically focused on the potential hypoxaemic effects of medetomidine. Sheep in all four studies developed hypoxaemia, as shown by the arterial partial pressure of oxygen, when administered intravenous medetomidine as part of a general anaesthetic protocol.

However, the strength of evidence was weak. The sheep were receiving various doses of medetomidine at various timepoints during anaesthesia. They received different quantities of supplemental oxygen, if oxygen was given at all, and there was varying ventilatory management. Two studies used mechanical ventilation, and two studies allowed the sheep to breathe spontaneously. Finally, different agents were used to maintain anaesthesia, meaning that overall, the clinical significance of the hypoxaemia that developed was difficult to assess.

In conclusion, in healthy adult female sheep administered intravenous medetomidine as part of an anaesthetic protocol, hypoxaemia can be expected. However, the hypoxaemia is variable, and its effects can be lessened with anaesthetic techniques such as the provision of supplemental oxygen. Finally, it should be noted that medetomidine is not licenced in food-producing animals in the UK, and adherence to the relevant legislation in the country of use is advised.

Thank you.

Intellectual Property Rights

Authors of Knowledge Summaries submitted to RCVS Knowledge for publication will retain copyright in their work, and will be required to grant to RCVS Knowledge a non-exclusive licence to publish including but not limited to the right to publish, re-publish, transmit, sell, distribute and otherwise use the materials in all languages and all media throughout the world, and to licence or permit others to do so.

Disclaimer

Knowledge Summaries are a peer-reviewed article type which aims to answer a clinical question based on the best available current evidence. It does not override the responsibility of the practitioner. Informed decisions should be made by considering such factors as individual clinical expertise and judgement along with patient’s circumstances and owners’ values. Knowledge Summaries are a resource to help inform and any opinions expressed within the Knowledge Summaries are the author's own and do not necessarily reflect the view of the RCVS Knowledge. Authors are responsible for the accuracy of the content. While the Editor and Publisher believe that all content herein are in accord with current recommendations and practice at the time of publication, they accept no legal responsibility for any errors or omissions, and make no warranty, express or implied, with respect to material contained within. For further information please refer to our Terms of Use.



Open Access